Category: PMCPA Case of the Week

Cases selected for the AskAnzal weekly PMCPA insight newsletter

2 Mar 2026

Colonis voluntary admission: wrong prescribing information in promotional letter for Melatonin Oral Solution

Colonis admitted a promotional letter for Melatonin 1mg/ml Oral Solution included prescribing information for Melatonin 3mg tablets. The…

27 Feb 2026

GSK breach upheld on taskforce website: sponsorship not clearly acknowledged β€œfrom the outset” (Clause 25.3)

GSK funded a patient-organisation-hosted taskforce. PMCPA found sponsorship disclosure wasn’t clear β€œfrom the outset” because it was only…

18 Feb 2026

AstraZeneca: promotional meeting misclassified and LinkedIn β€˜likes/reposts’ led to pre-authorisation promotion and public advertising concerns (AUTH/3729/1/23)

Six complaints against AstraZeneca. Breaches found for a UK meeting treated as non-promotional (certification/PI and β€˜cure’ claims) and…

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training